RTX Corp: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Jul 26, 2019 and accepted by EDGAR at Jul 26, 2019, 06:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-04-01 to 2019-06-30 | $19.63bn | us-gaap:Revenues |
| Revenue | 6 months2019-01-01 to 2019-06-30 | $38.00bn | us-gaap:Revenues |
| Research and development | 3 months2019-04-01 to 2019-06-30 | $743.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2019-01-01 to 2019-06-30 | $1.47bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-04-01 to 2019-06-30 | $2.11bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-01-01 to 2019-06-30 | $4.10bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-04-01 to 2019-06-30 | $2.58bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | $4.63bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $360.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $791.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-04-01 to 2019-06-30 | $441.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-01-01 to 2019-06-30 | $838.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-04-01 to 2019-06-30 | $1.90bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | $3.25bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | $2.20 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | $3.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-04-01 to 2019-06-30 | $2.22 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-01-01 to 2019-06-30 | $3.80 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-04-01 to 2019-06-30 | 863,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-01-01 to 2019-06-30 | 862,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $3.61bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months2019-01-01 to 2019-06-30 | $830.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 6 months2019-01-01 to 2019-06-30 | $1.22bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2019-01-01 to 2019-06-30 | $69.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-06-30 | $6.82bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $37.06bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $138.99bn | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $35.42bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-06-30 | $95.90bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2019-06-30 | $1.14bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-06-30 | $40.75bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-06-30 | 862,831,280 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-19-000038. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.